⌘K
OverviewStock screenerAnalyst actionsCalendar
MarketsInvestorsSign in
StockUnited StatesNasdaqGM

ATAI

AtaiBeckley Inc.

Healthcare · Biotechnology

7.29USD

+0.0100 (+0.14%)

DescriptionHistoricalFinancialsRelative ValueResearchNewsDiscussionOptionsPrice Chart ↗Fundamental Chart ↗

Fetching financial statements from SEC filings…

In $M except per-shareQ2 FY26Q1 FY26Q2 FY25Q1 FY25
Revenue2112
Cost of Revenue————
Gross Profit————
Operating Income-44-31-25-20
Net Income-33-30-28-26
EPS (Diluted)$-0.09$-0.08$-0.14$-0.15

Source: SEC filings (EDGAR)